Stryker Corporation (NYSE:SYK) Shares Sold by Choreo LLC

Choreo LLC lessened its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 6.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,414 shares of the medical technology company's stock after selling 1,056 shares during the quarter. Choreo LLC's holdings in Stryker were worth $6,110,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the business. Continuum Advisory LLC raised its position in shares of Stryker by 5.8% during the 1st quarter. Continuum Advisory LLC now owns 532 shares of the medical technology company's stock worth $198,000 after purchasing an additional 29 shares during the last quarter. Oakworth Capital Inc. raised its position in shares of Stryker by 0.5% during the 1st quarter. Oakworth Capital Inc. now owns 6,133 shares of the medical technology company's stock worth $2,283,000 after purchasing an additional 29 shares during the last quarter. Rinkey Investments raised its position in shares of Stryker by 1.1% during the 4th quarter. Rinkey Investments now owns 2,712 shares of the medical technology company's stock worth $976,000 after purchasing an additional 30 shares during the last quarter. Tritonpoint Wealth LLC raised its position in shares of Stryker by 0.7% during the 1st quarter. Tritonpoint Wealth LLC now owns 4,042 shares of the medical technology company's stock worth $1,508,000 after purchasing an additional 30 shares during the last quarter. Finally, Cornerstone Advisory LLC raised its position in shares of Stryker by 0.6% during the 4th quarter. Cornerstone Advisory LLC now owns 5,256 shares of the medical technology company's stock worth $2,024,000 after purchasing an additional 31 shares during the last quarter. Hedge funds and other institutional investors own 77.09% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on SYK. Sanford C. Bernstein set a $450.00 price objective on Stryker in a research report on Monday, May 5th. Evercore ISI boosted their price target on Stryker from $390.00 to $415.00 and gave the company an "outperform" rating in a report on Tuesday, July 8th. Truist Financial boosted their price target on Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a report on Monday, May 5th. JMP Securities reiterated a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Finally, BTIG Research reiterated a "buy" rating on shares of Stryker in a report on Monday, July 14th. Four analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $428.55.

Stryker Stock Up 1.7%

Stryker stock traded up $6.68 during trading on Friday, reaching $403.34. 963,567 shares of the company's stock were exchanged, compared to its average volume of 1,155,846. The company's 50-day moving average is $386.37 and its two-hundred day moving average is $379.33. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. Stryker Corporation has a 52-week low of $314.93 and a 52-week high of $406.19. The firm has a market cap of $153.95 billion, a price-to-earnings ratio of 54.51, a PEG ratio of 2.99 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The firm's revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the prior year, the company posted $2.50 EPS. On average, analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be given a $0.84 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.83%. Stryker's payout ratio is currently 45.41%.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the transaction, the director directly owned 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This represents a 5.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 5.90% of the stock is currently owned by insiders.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.